Gastrointestinal biomarkers

Gastrointestinal biomarkers are useful for diagnosing and managing various gastrointestinal disorders and diseases. RBM's biomarkers can help evaluate new GI therapeutics.

Biomarkers such as C-reactive protein (CRP), fecal calprotectin, and lactoferrin indicate inflammation in the gastrointestinal tract, useful in conditions like inflammatory bowel disease (IBD). Serum gastrin and pepsinogen levels help diagnose and monitor peptic ulcer disease and gastritis. Liver enzymes like alanine transaminase (ALT) and aspartate transaminase (AST) are essential for assessing liver function and detecting liver diseases. Carbohydrate antigen 19-9 (CA 19-9) and alpha-fetoprotein (AFP) serve as tumor markers for gastrointestinal cancers. Pancreatic enzymes like amylase and lipase aid in diagnosing pancreatitis. These biomarkers provide valuable information on the underlying pathophysiology and can  be useful in evaluating safety and efficacy of therapeutic candidates.

Multiplexes with GI biomarkers

• Discovery MAP
• Human MAP